InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Adams Kendra, Chief Financial Officer. Officer active across 1 companies, notably C4 Therapeutics, Inc.. Aggregated, 2 disclosures have been published. The latest transaction was filed on 18 September 2025 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
06,250 shares0
Common Stock
SEC:0001470831-25-000223·
06,250 shares0
Common Stock
SEC:0001470831-25-000223:0·
2 of 2 declarations
About Adams Kendra
Adams Kendra is the Chief Financial Officer at C4 Therapeutics, Inc. In this role, she is responsible for the company's financial management, including budgeting and financial analysis. Her expertise is crucial in ensuring the financial health of the organization.
